HGH
Get informed when a big investor buys or sells
+ FollowJuly 24, 2026 - AI Summary
Overvalued by 0% based on the discounted cash flow analysis.
| Market cap | $38.90 Billion |
|---|---|
| Enterprise Value | $43.15 Billion |
| Dividend Yield | $1.97 (1.63%) |
| Earnings per Share | $0.01 |
| Beta | 0.07 |
| Outstanding Shares | 278,300,000 |
| P/E Ratio | 9.09 |
|---|---|
| PEG | 29.85 |
| Price to Sales | 0.24 |
| Price to Book Ratio | 0.36 |
| Enterprise Value to Revenue | 1.49 |
| Enterprise Value to EBIT | 15.25 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.22 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data